Mireia M. M. L.
- Country
- Spain
- Department
- Rheumatology
Research Overview
- Evaluation of ERAP Inhibition in Patients with Axial Spondyloarthritis: The EAST-1 Clinical Trial
- Effect of Upadacitinib on the Frequency of Acute Recurrent Anterior Uveitis in Patients With Axial Spondyloarthritis: A Real-World Study
- Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Adults With Active Psoriatic Arthritis: A Phase 3 Extension Study
Data & Insights
Has run more than one trial at 128 of 279 partner sites.
Specializations
Inflammatory Arthritis
This investigator specializes in treating psoriatic arthritis, with particular emphasis on managing complex cases that have shown inadequate response to conventional therapies.
- Treatment-resistant psoriatic arthritis
- Biologic therapy assessment
- DMARD therapy optimization
Their research extends to evaluating novel therapeutic approaches for patients with active disease states.
Therapeutic Innovation
The investigator focuses on studying advanced biological treatments for inflammatory joint conditions, particularly evaluating new therapeutic options for psoriatic arthritis patients.
- Novel biologics evaluation
- Treatment response assessment
- Long-term disease management
Their work includes assessment of treatment efficacy in both treatment-naive and therapy-experienced patients.
Clinical Assessment
Expertise in evaluating disease manifestations and therapeutic responses in inflammatory arthritis, with focus on measuring reduction in signs and symptoms.
- Disease activity monitoring
- Treatment efficacy assessment
- Patient response evaluation
Their research encompasses comprehensive assessment of therapeutic interventions in active psoriatic arthritis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.